These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34467805)

  • 21. Opioid Use Disorder and Prescribed Opioid Regimens: Evidence from Commercial and Medicaid Claims, 2005-2015.
    Ali MM; Cutler E; Mutter R; Henke RM; O'Brien PL; Pines JM; Mazer-Amirshahi M; Diou-Cass J
    J Med Toxicol; 2019 Jul; 15(3):156-168. PubMed ID: 31152355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discontinuation and tapering of prescribed opioids and risk of overdose among people on long-term opioid therapy for pain with and without opioid use disorder in British Columbia, Canada: A retrospective cohort study.
    Kennedy MC; Crabtree A; Nolan S; Mok WY; Cui Z; Chong M; Slaunwhite A; Ti L
    PLoS Med; 2022 Dec; 19(12):e1004123. PubMed ID: 36454732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel mHealth application for improving HIV and Hepatitis C knowledge in individuals with opioid use disorder: A pilot study.
    Ochalek TA; Heil SH; Higgins ST; Badger GJ; Sigmon SC
    Drug Alcohol Depend; 2018 Sep; 190():224-228. PubMed ID: 30056321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identifying Areas with Disproportionate Local Health Department Services Relative to Opioid Overdose, HIV and Hepatitis C Diagnosis Rates: A Study of Rural Illinois.
    McLuckie C; Pho MT; Ellis K; Navon L; Walblay K; Jenkins WD; Rodriguez C; Kolak MA; Chen YT; Schneider JA; Zahnd WE
    Int J Environ Res Public Health; 2019 Mar; 16(6):. PubMed ID: 30893862
    [No Abstract]   [Full Text] [Related]  

  • 25. Examination of the Hepatitis C Virus care continuum among individuals with an opioid use disorder in substance use treatment.
    Brown JL; Gause NK; Lewis D; Winhusen T
    J Subst Abuse Treat; 2017 May; 76():77-80. PubMed ID: 28162850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis C Virus Cascade of Care Among Perinatal Patients in Maine Diagnosed With Opioid Use Disorder, 2015-2020.
    Pfeiffer M; O'Connor A; Zimmerman C; Thakarar K; Ahrens K
    J Addict Med; 2023 May-Jun 01; 17(3):286-293. PubMed ID: 37267170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The importance of social risk factors for patients diagnosed with opioid use disorder.
    Arsene C; Na L; Patel P; Vaidya V; Williamson AA; Singh S
    J Am Pharm Assoc (2003); 2023; 63(3):925-932. PubMed ID: 36935292
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.
    Puzhko S; Roy É; Jutras-Aswad D; Artenie AA; Fortier E; Zang G; Bruneau J
    Int J Drug Policy; 2017 Sep; 47():61-68. PubMed ID: 28666636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioid analgesic prescribing for opioid-naïve individuals prior to identification of opioid use disorder in British Columbia, Canada.
    Enns B; Krebs E; Thomson T; Dale LM; Min JE; Nosyk B
    Addiction; 2021 Dec; 116(12):3422-3432. PubMed ID: 33861882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "I Refused to Get Addicted to Opioids": Exploring Attitudes About Opioid Use Disorder in Patients With Advanced Cancer Pain and Their Support People.
    Bulls HW; Hamm M; Wasilko R; Cameron FA; Belin S; Goodin BR; Liebschutz JM; Wozniak A; Sabik LM; Schenker Y; Merlin JS
    J Pain; 2023 Jun; 24(6):1030-1038. PubMed ID: 36709854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High prevalence of co-occurring substance use in individuals with opioid use disorder.
    Mahoney JJ; Winstanley EL; Lander LR; Berry JH; Marshalek PJ; Haut MW; Marton JL; Kimble WD; Armistead M; Wen S; Cai Y; Hodder SL
    Addict Behav; 2021 Mar; 114():106752. PubMed ID: 33348147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C.
    Whitehead AJ; Dobscha SK; Morasco BJ; Ruimy S; Bussell C; Hauser P
    J Pain Symptom Manage; 2008 Jul; 36(1):39-45. PubMed ID: 18358690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Implementation of hepatitis C screening within a pharmacist-managed medication-assisted therapy opioid use disorder protocol program.
    Llayton CK; Harlow CP; Burris JN; Rhodes J
    J Am Pharm Assoc (2003); 2020; 60(6):e307-e311. PubMed ID: 32527703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the COVID-19 response: The potential role of telehealth, medications for opioid use disorder and minimal demands on patients.
    Sivakumar A; Madden L; DiDomizio E; Eller A; Villanueva M; Altice FL
    Int J Drug Policy; 2022 Mar; 101():103570. PubMed ID: 34954493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs.
    Rosenthal ES; Silk R; Mathur P; Gross C; Eyasu R; Nussdorf L; Hill K; Brokus C; D'Amore A; Sidique N; Bijole P; Jones M; Kier R; McCullough D; Sternberg D; Stafford K; Sun J; Masur H; Kottilil S; Kattakuzhy S
    Clin Infect Dis; 2020 Oct; 71(7):1715-1722. PubMed ID: 32009165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US.
    Han B; Jones CM; Einstein EB; Compton WM
    JAMA Netw Open; 2021 Oct; 4(10):e2129409. PubMed ID: 34652446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Missed Opportunities for HIV and Hepatitis C Screening Among Emergency Department Patients With Untreated Opioid Use Disorder.
    Lyons MS; Chawarski MC; Rothman R; Whiteside L; Cowan E; Richardson LD; Hawk K; Tsui JI; Schwartz RP; O'Connor P; D'Onofrio G; Fiellin DA; Edelman EJ
    J Addict Med; 2023 Mar-Apr 01; 17(2):210-214. PubMed ID: 36170184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analgesic Opioid Misuse and Opioid Use Disorder among Patients with Chronic Non-Cancer Pain and Prescribed Opioids in a Pain Centre in France.
    Guillou-Landreat M; Quinio B; Le Reste JY; Le Goff D; Fonsecca J; Grall-Bronnec M; Dany A
    Int J Environ Res Public Health; 2021 Feb; 18(4):. PubMed ID: 33670004
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex-Specific Risk Factors and Health Disparity Among Hepatitis C Positive Patients Receiving Pharmacotherapy for Opioid Use Disorder: Findings From a Propensity Matched Analysis.
    Dennis BB; Martin LJ; Naji L; Akhtar D; Cholankeril G; Kim D; Sanger N; Hillmer A; Chawar C; D'Elia A; Panesar B; Worster A; Marsh DC; O'Shea T; Bawor M; Thabane L; Samaan Z; Ahmed A
    J Addict Med; 2022 Jul-Aug 01; 16(4):e248-e256. PubMed ID: 34799492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HCV elimination in a Swiss opioid agonist therapy programme - a cohort study.
    Bregenzer A; Krismer C; Wendel S; Roser P; Fux CA
    Swiss Med Wkly; 2022 Dec; 152():40009. PubMed ID: 36509421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.